- ASSOCIATE PROFESSOR Rehabilitation Medicine
PhD, University at Albany, State University of New York
BA, Colgate University
Dr. Dams-O'Connor is Co-Director of the Brain Injury Research Center of Mount Sinai, a clinical neuropsychologist and Associate Professor in the Department of Rehabilitation Medicine at Icahn School of Medicine at Mount Sinai in New York, NY.
She completed a postdoctoral fellowship in clinical neuropsychology at Mount Sinai Medical Center, and a predoctoral internship in neurorehabilitation at the Rusk Institute of Rehabilitation Medicine at New York University Medical Center. She received her Ph.D. from the University at Albany.
She has published over 40 peer-reviewed manuscripts and chapters on traumatic brain injury treatments and outcomes, and has presented her research internationally. Her primary fields of clinical and research expertise are in long-term outcomes after brain injury, neuropsychological assessment, and cognitive rehabilitation for individuals with neurological diseases.
Current projects focus on applying modern psychometric and statistical techniques to measure individual differences in trajectories of change over time among survivors of TBI. Her research is currently supported by federal grants from the National Institutes of Health, National Institute for Disability and Rehabilitation Research, and Centers for Disease Control. She is also Director of Research in the Mount Sinai Injury Control Research Center, and a co-investigator in the New York Traumatic Brain Injury Model System.
International Brain Injury Association Early Career Investigator Award
International Brain Injury Association
Dr. Dams-O'Connor is involved in research on traumatic brain injury (TBI). She is currently involved in a variety of projects and clinical trials in the following topics:
- Long-term outcomes and aging with TBI
- In-vivo markers of post-TBI neurodegeneration
- Sports concussion
- Application of modern statistical and psychometric methods to TBI research
- Neuroimaging and proteomics in TBI
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Dams-O'Connor did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.